Real-World Study & Application Centre
What are Real-World Data and Real-World Evidence?
Real-World Data (RWD) is information collected from routine clinical practice. Real-World Evidence (RWE) is the clinical evidence derived from the analysis of RWD to understand how treatments perform in real life settings. Together, they improve quality of patient care, inform healthcare decisions, and drive medical innovation. RWE complements, rather than replaces, traditional clinical trials.
Advantages of Hong Kong
World-Class Medical Database
Hong Kong's Hospital Authority Clinical Management System offers a standardized database with nearly 30 years of data from 43 public hospitals and 123 clinics, covering 11 million patients—an ideal resource for real-world studies.
Top-Tier International Experts
Hong Kong unites leading global experts in real-world studies, with proven success in using data for drug approvals, public health policy, and clinical trial design.
Special Measure for Collaboration
The Measure of using HK registered drugs and medical devices used in HK public hospitals in GBA enables cross-border use of innovative Hong Kong drugs and devices in GBA institutions, generating data to support drug registration.
Our Vision
Unlocking RWE to Revolutionize Health and Human Potential
Our Mission
To advance healthcare innovation by unlocking real-world health data, fostering seamless collaboration between Hong Kong, Macau, and Chinese Mainland, especially by integrating real-world data generated through Measure of using HK registered drugs and medical devices used in HK public hospitals in GBA.
Our Objectives
To accelerate the development, regulatory approval, and market access of innovative medical products.
To leverage RWD to inform evidence-based decision-making, thereby optimizing treatment strategies and enhancing health system efficiency.
To position Hong Kong as a leading region and global hub for real-world studies, attracting international collaboration and investment.
Our Services
- 1. Leverage RWD to assess study feasibility and identify suitable sites for clinical trials.
- 2. Provide comprehensive, end-to-end project management for RWE studies in Hong Kong and the GBA.
- 3. Strengthen single-arm trials by developing robust RWD-based external control arms.
- 4. Offer expert advisory services, professional training and capacity building in Real-World Studies.
